AstraZeneca release a video on its strategy of taking on the battle against bacteria and viruses that resist antibiotics.
The company, which has research, administrative and manufacturing sites in Delaware, recently announced a new partnership.
“Our two-year collaboration with the Broad Institute, announced in September 2012, combines our unique resources and strong histories in innovation to accelerate successful research. Broad is working to identify potential new anti-bacterial and anti-viral targets from their chemical library of over 100,000 compounds. We will then help to develop any that show promise as potential new treatments,” the company stated.